Neuroglee Therapeutics logo

Neuroglee Therapeutics

Biotechnology

2-10 Employees

0.0 (Glassdoor)

Unclaimed
Page has not been claimed by the company yet.

About Neuroglee Therapeutics

Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, our digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence. Our lead product, NG-001 is a prescription software intended for treatment of MCI and patients with early stage Alzheimer’s Disease. For more information, visit us at www.neuroglee.com 

Neuroglee Therapeutics Salaries

Neuroglee Therapeutics Reviews

ADD A REVIEW

Neuroglee Therapeutics Careers and Jobs (1)

(View all 1 jobs)

Neuroglee Therapeutics Culture

Neuroglee Therapeutics has not added their culture yet. Add them for FREE now!

Neuroglee Therapeutics Employee Benefits

Neuroglee Therapeutics has not added their benefits yet. Add them for FREE now!

Neuroglee Therapeutics Insights

Team Trend


Team Breakdown


Company

Frequently Asked Questions about Neuroglee Therapeutics

Neuroglee Therapeutics has 2-10 employees globally.

More about Neuroglee Therapeutics: Salaries | Reviews | Jobs | Culture | Benefits
Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, our digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence. Our lead product, NG-001 is a prescription software intended for treatment of MCI and patients with early stage Alzheimer’s Disease. For more information, visit us at www.neuroglee.com 
There are 1 Neuroglee Therapeutics jobs right now. Explore jobs like Senior Machine Learning Scientist and more.